The first is through affecting multiple balance systems, such as oxidation-antioxidant balance, protein homeostasis and mitochondrial quality control, the second is through regulating the gene transcription and translation processes of intracellular DKD-related pathogenic molecules, such as PKC activation and hexosamine pathway hyperactivation. The gene discussed is PRRT2; the disease is diabetic kidney disease.